Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
Kom GD, Schwedhelm E, Nielsen P, Böger RH. Kom GD, et al. Free Radic Biol Med. 2006 Apr 1;40(7):1194-200. doi: 10.1016/j.freeradbiomed.2005.11.004. Epub 2005 Dec 13. Free Radic Biol Med. 2006. PMID: 16545687
Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.
Kom GD, Schwedhelm E, Maas R, Schneider L, Benndorf R, Böger RH. Kom GD, et al. Br J Clin Pharmacol. 2007 Jun;63(6):672-9. doi: 10.1111/j.1365-2125.2006.02832.x. Epub 2007 Jan 3. Br J Clin Pharmacol. 2007. PMID: 17214829 Free PMC article. Clinical Trial.
Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
Benndorf RA, Schwedhelm E, Gnann A, Taheri R, Kom G, Didié M, Steenpass A, Ergün S, Böger RH. Benndorf RA, et al. Among authors: kom g. Circ Res. 2008 Oct 24;103(9):1037-46. doi: 10.1161/CIRCRESAHA.108.184036. Epub 2008 Sep 18. Circ Res. 2008. PMID: 18802021
Redox-generated isoprostanes are associated with residual platelet activity in aspirin-treated patients with stable coronary heart disease.
Schwedhelm E, Bierend A, Maas R, Trinks R, Kom GD, Tsikas D, Böger RH. Schwedhelm E, et al. Among authors: kom gd. J Thromb Haemost. 2010 Dec;8(12):2662-70. doi: 10.1111/j.1538-7836.2010.04117.x. J Thromb Haemost. 2010. PMID: 20961392 Free article.
Postocclusive reactive hyperemia inversely correlates with urinary 15-F2t-isoprostane levels in systemic sclerosis.
Cracowski JL, Kom GD, Salvat-Melis M, Renversez JC, McCord G, Boignard A, Carpentier PH, Schwedhelm E. Cracowski JL, et al. Among authors: kom gd. Free Radic Biol Med. 2006 May 15;40(10):1732-7. doi: 10.1016/j.freeradbiomed.2006.01.014. Epub 2006 Feb 7. Free Radic Biol Med. 2006. PMID: 16678012
Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis.
Broedbaek K, Poulsen HE, Weimann A, Kom GD, Schwedhelm E, Nielsen P, Böger RH. Broedbaek K, et al. Among authors: kom gd. Free Radic Biol Med. 2009 Oct 15;47(8):1230-3. doi: 10.1016/j.freeradbiomed.2009.08.004. Epub 2009 Aug 14. Free Radic Biol Med. 2009. PMID: 19686840
Correlation of biomarkers of endothelium dysfunction and matrix remodeling in patients with systemic sclerosis.
Blaise S, Maas R, Trocme C, Kom GD, Roustit M, Carpentier PH, Cracowski JL. Blaise S, et al. Among authors: kom gd. J Rheumatol. 2009 May;36(5):984-8. doi: 10.3899/jrheum.080924. Epub 2009 Mar 30. J Rheumatol. 2009. PMID: 19332631